For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Takashi Shoda, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshio Takahashi, Corporate Officer in Charge,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.co.jp/
Announcement of Revisions to Sankyo's Consolidated Financial Results for Prior Fiscal Years
Tokyo, March 30, 2006 - DAIICHI SANKYO COMPANY, LIMITED has announced that revisions to consolidated financial results for prior fiscal years have been made to its subsidiary, Sankyo Co., Ltd. These revisions do not affect the company's financial statements.
1. Revised Documents
(1) Consolidated Financial Results for the Interim Period of Fiscal 2003 (Release date: November 7, 2003)
(2) Consolidated Financial Results for Fiscal 2003 (Release date: May 14, 2004)
(3) Consolidated Financial Results for the Interim Period of Fiscal 2004 (Release date: November 5, 2004)
(4) Consolidated Financial Results for Fiscal 2004 (Release date: May 13, 2005)
(5) Consolidated Financial Results for the Interim Period of Fiscal 2005 (Release date: November 7, 2005)
2. Revised Items
Production, Orders and Sales (1) Production
3. Revised Content
The revised figures have been underlined.
(1) Consolidated Financial Results for the Interim Period of Fiscal 2003 (page 39 of English version)
(Before revisions)
Production by operating segment for the interim period of fiscal 2003 is summarized as follows:
| Operating segment |
Amount
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
153,692 |
106.3 |
| Other |
35,251 |
88.6 |
| Total |
188,944 |
102.5 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(After revisions)
Production by operating segment for the interim period of fiscal 2003 is summarized as follows:
| Operating segment |
Sales
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
159,075 |
110.0 |
| Other |
42,135 |
105.8 |
| Total |
201,210 |
109.1 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(2) Consolidated Financial Results for Fiscal 2003 (page 45 of English version)
(Before revisions)
Production by operating segment for the interim period of fiscal 2003 is summarized as follows:
| Operating segment |
Amount
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
309,267 |
97.0 |
| Other |
75,340 |
87.3 |
| Total |
384,607 |
94.9 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(After revisions)
Production by operating segment for the interim period of fiscal 2003 is summarized as follows:
| Operating segment |
Sales
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
319,775 |
100.3 |
| Other |
91,740 |
106.3 |
| Total |
411,516 |
101.6 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(3) Consolidated Interim Financial Results for the Interim Period of Fiscal 2004
(page 41 of English version)
(Before revisions)
Production by operating segment for the interim period of fiscal 2004 is summarized as follows:
| Operating segment |
Amount
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
170,618 |
111.0 |
| Other |
36,063 |
102.3 |
| Total |
206,681 |
109.4 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(After revisions)
Production by operating segment for the interim period of fiscal 2004 is summarized as follows:
| Operating segment |
Sales
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
179,949 |
113.1 |
| Other |
42,816 |
101.6 |
| Total |
222,766 |
110.7 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(4) Consolidated Financial Results for Fiscal 2004 (page 49 of English version)
(Before revisions)
Production by operating segment for the interim period of fiscal 2004 is summarized as follows:
| Operating segment |
Amount
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
317,646 |
102.7 |
| Other |
77,752 |
103.2 |
| Total |
395,399 |
102.8 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(After revisions)
Production by operating segment for the interim period of fiscal 2004 is summarized as follows:
| Operating segment |
Sales
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
342,284 |
107.0 |
| Other |
93,065 |
101.4 |
| Total |
435,350 |
105.8 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(5) Consolidated Interim Financial Results for the Interim Period of Fiscal 2005
(page 37 of English version)
(Before revisions)
Production by operating segment for the interim period of fiscal 2005 is summarized as follows:
| Operating segment |
Amount
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
155,728 |
91.3 |
| Other |
33,106 |
91.8 |
| Total |
188,835 |
91.4 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
(After revisions)
Production by operating segment for the interim period of fiscal 2005 is summarized as follows:
| Operating segment |
Sales
(Millions of yen) |
Year-on-year changes (%) |
| Pharmaceuticals |
179,147 |
99.6 |
| Other |
39,820 |
93.0 |
| Total |
218,967 |
98.3 |
Notes:
1. Production amounts are based on net selling prices and are after elimination of inter-segment sales.
2. The above amounts are stated exclusive of consumption tax.
End